Cipla Gains Nearly 5% On Settlement of US Patent Litigation

The pharma major has announced settlement of its patent litigation with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, in the United States

from NDTV Profit - Latest https://ift.tt/2KpyE7b
via